title: Letter to the editor: melanocortin 4 receptor antagonists and their emerging role in pain management.
authors.forename: Shailendra
authors.initials: S
authors.lastname: Kapoor
mesh_terms: D000818:Animals; D005727:Ganglia, Spinal / Q000378:metabolism*; D006930:Hyperalgesia / Q000188:drug therapy*; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D009437:Neuralgia / Q000188:drug therapy*; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D044105:Receptor, Melanocortin, Type 4 / Q000502:physiology*; D012584:Sciatic Nerve / Q000293:injuries*; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
chemical_list: D007093:Imidazoles; D010456:Peptides, Cyclic; D011725:Pyridines; D044105:Receptor, Melanocortin, Type 4; D048051:p38 Mitogen-Activated Protein Kinases